CLICK on the image to see it in a larger size
See more products at:
Description
Combine it with
Επιλέξτε τα υποχρεωτικά πεδία.
Features
In depth analysis
Summer
Dreams with colors borrowed from the Greek islands.
Flavors which they remind of summer memories.
A familiar scent that travels you to the carefree holidays.
Juicy exotic fruits, blueberries and raspberries, sweet watermelon and the ultimate Greek summer drink, ouzo, mingle with each other in imaginative combinations that guarantee a refreshing swim in enjoyment!
In depth analysis
AQUARIUS PROJECT
Aquarius Project was established through the pioneer alliance of NOBACCO and LMBI Laboratory of Molecular Biology and Immunology), Pharmaceutical Dept, Patras University.
NOBACCO’s partnership with the LMBI, Pharmaceutical Dept, Patras University is a pioneer initiative which puts the collaboration of the academic community with the private sector into practice, following the international trend to connect production with knowledge and innovation.
AQUARIUS PROJECT is the first company in Greece that emerged with the sole purpose of specializing in the production of e-liquids. All manufacturing procedures adhere to the strictest international standards.
The company’s driving force is the investment in the Greek research and innovation, such as the formation of the strategic alliance with the LMBI (Laboratory of Molecular Biology and Immunology), Pharmaceutical Dept, Patras University from 2014 to 2019.
Aquarius Project’s mission is to develop innovative products for millions of Electronic Nicotine Delivery Systems’ users (ENDS) in the world, abiding by the strictest international standards.
Its vision is to create a line of products that will gain the trust of vapers around the world, and will add value to the production and entrepreneurship of Greece.
NOBACCO’s partnership with the LMBI, Pharmaceutical Dept, Patras University is a pioneer initiative which puts the collaboration of the academic community with the private sector into practice, following the international trend to connect production with knowledge and innovation.
AQUARIUS PROJECT is the first company in Greece that emerged with the sole purpose of specializing in the production of e-liquids. All manufacturing procedures adhere to the strictest international standards.
The company’s driving force is the investment in the Greek research and innovation, such as the formation of the strategic alliance with the LMBI (Laboratory of Molecular Biology and Immunology), Pharmaceutical Dept, Patras University from 2014 to 2019.
Aquarius Project’s mission is to develop innovative products for millions of Electronic Nicotine Delivery Systems’ users (ENDS) in the world, abiding by the strictest international standards.
Its vision is to create a line of products that will gain the trust of vapers around the world, and will add value to the production and entrepreneurship of Greece.
Contents of Package
Combine it with
Επιλέξτε τα υποχρεωτικά πεδία.
Features
In depth analysis
Summer
Dreams with colors borrowed from the Greek islands.
Flavors which they remind of summer memories.
A familiar scent that travels you to the carefree holidays.
Juicy exotic fruits, blueberries and raspberries, sweet watermelon and the ultimate Greek summer drink, ouzo, mingle with each other in imaginative combinations that guarantee a refreshing swim in enjoyment!
In depth analysis
AQUARIUS PROJECT
Aquarius Project was established through the pioneer alliance of NOBACCO and LMBI Laboratory of Molecular Biology and Immunology), Pharmaceutical Dept, Patras University.
NOBACCO’s partnership with the LMBI, Pharmaceutical Dept, Patras University is a pioneer initiative which puts the collaboration of the academic community with the private sector into practice, following the international trend to connect production with knowledge and innovation.
AQUARIUS PROJECT is the first company in Greece that emerged with the sole purpose of specializing in the production of e-liquids. All manufacturing procedures adhere to the strictest international standards.
The company’s driving force is the investment in the Greek research and innovation, such as the formation of the strategic alliance with the LMBI (Laboratory of Molecular Biology and Immunology), Pharmaceutical Dept, Patras University from 2014 to 2019.
Aquarius Project’s mission is to develop innovative products for millions of Electronic Nicotine Delivery Systems’ users (ENDS) in the world, abiding by the strictest international standards.
Its vision is to create a line of products that will gain the trust of vapers around the world, and will add value to the production and entrepreneurship of Greece.
NOBACCO’s partnership with the LMBI, Pharmaceutical Dept, Patras University is a pioneer initiative which puts the collaboration of the academic community with the private sector into practice, following the international trend to connect production with knowledge and innovation.
AQUARIUS PROJECT is the first company in Greece that emerged with the sole purpose of specializing in the production of e-liquids. All manufacturing procedures adhere to the strictest international standards.
The company’s driving force is the investment in the Greek research and innovation, such as the formation of the strategic alliance with the LMBI (Laboratory of Molecular Biology and Immunology), Pharmaceutical Dept, Patras University from 2014 to 2019.
Aquarius Project’s mission is to develop innovative products for millions of Electronic Nicotine Delivery Systems’ users (ENDS) in the world, abiding by the strictest international standards.
Its vision is to create a line of products that will gain the trust of vapers around the world, and will add value to the production and entrepreneurship of Greece.
Similar products
Follow us on Social Media
This site contains potentially reduced risk products that may be harmful to health and is intended for adult smokers only. Purchase and use by persons under the age of 18 is prohibited. NOBACCO products containing nicotine, which is a highly addictive substance, are not suitable for use by: Persons under the age of 18, pregnant or breastfeeding persons, persons who are sensitive or allergic to nicotine and they are not recommended for use by people with heart disease or hypertension. Keep away from children.
No. ESA Register: 119582601000
